Breast cancer (BrC) has the highest incidence among females world over and it is one of the most common causes of death from cancer overall. Its high mortality is mostly due to its propensity to rapidly spread to other organs through lymphatic and blood vessels in spite of proper treatment. Bladder metastases from BrC are rare, with 50 cases having been reported in the last 60 years. This review aims to discuss some critical points regarding this uncommon condition. First, we performed a systematic review of the literature in order to draw a clinical and pathological profile of this entity. On this basis, its features in terms of diagnostic issues, imaging techniques, and survival are critically examined. Most bladder metastases from BrC are secondary lobular carcinoma, which mimic very closely the rare variant of urothelial cancer with lobular carcinoma-like features (uniform cells with an uncohesive single-cell, diffusely invasive growth pattern); thus, immunohistochemistry is mandatory to arrive at a correct diagnosis. This article summarizes the current knowledge regarding the incidence, clinical presentation, diagnosis, prognosis, and treatment of bladder metastases in patients with BrC.

Keywords:
Bladder, Metastasis, Breast cancer, Pathology, Oncology
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
2.
Bates AW, Baithun SI: Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology 2000; 36: 32–40.
3.
Abrams HL, Spiro R, Goldstein N: Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950; 3: 74–85.
4.
Bates AW, Baithun SI: The significance of secondary neoplasms of the urinary and male genital tract. Virchows Arch 2002; 440: 640–647.
5.
Elia G, Stewart S, Makhuli ZN, Krenzer BE, Mathur S, Simon HM, Mehdi S: Metastatic breast cancer diagnosed during a work-up for urinary incontinence: a case report. Int Urogynecol J Pelvic Floor Dysfunct 1999; 10: 39–42.
6.
Silverstein LI, Plaine L, Davis JE, Kabakow B: Breast carcinoma metastatic to bladder. Urology 1987; 29: 544–547.
7.
Feldman PA, Madeb R, Naroditsky I, Halachmi S, Nativ O: Metastatic breast cancer to the bladder: a diagnostic challenge and review of the literature. Urology 2002; 59: 138.
8.
Goldstein AG: Metastatic carcinoma to the bladder. J Urol 1967; 98: 209–215.
9.
Pontes JE, Oldford JR: Metastatic breast carcinoma to the bladder. J Urol 1970; 104: 839–842.
10.
Hagemeister FB Jr, Buzdar AU, Luna MA, Blumenschein GR: Causes of death in breast cancer: a clinicopathologic study. Cancer 1980; 46: 162–167.
11.
Saphir O, Parker ML: Metastasis of primary carcinoma of the breast, with special reference to spleen, adrenal glands and ovaries. Arch Surg 1941; 42: 1003–1018.
12.
Warren S, Witham EM: Studies on tumour metastasis; distribution of metastases in cancer of breast. Surg Gynecol Obstet 1933; 57: 81–85.
13.
Velcheti V, Govindan R: Metastatic cancer involving bladder: a review. Can J Urol 2007; 14: 3443–3448.
14.
Klinger ME: Secondary tumors of the genito-urinary tract. J Urol 1951; 65: 144–153.
15.
Melicow MM: Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol 1955; 74: 498–521.
16.
Xiao GQ, Chow J, Unger PD: Metastatic tumors to the urinary bladder: clinicopathologic study of 11 cases. Int J Surg Pathol 2012; 20: 342–348.
17.
Lakhani SR, Ellis IO, Schnitt SJ, et al: WHO Classification of Tumours of the Breast, ed 4. Lyon, IARC, 2012.
18.
Martinez V, Azzopardi JG: Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 1979; 3: 467–488.
19.
Borst MJ, Ingold JA: Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993; 114: 637–641.
20.
Siegel R, Naishadham D, Jemal A: Global cancer statistics. CA Cancer J Clin 2012; 62: 10–29.
21.
Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE: Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000; 88: 2561–2569.
22.
Cornford EJ, Wilson AR, Athanassiou E, Galea M, Ellis IO, Elston CW, Blamey RW: Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis. Br J Radiol 1995; 68: 450–453.
23.
Sant M; Eurocare Working Group: Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001; 93: 894–901.
24.
Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Moeller H, Paci E, Raverdy N, Tretarre B, Williams EM: Breast carcinoma survival in Europe and the United States. Cancer 2004; 100: 715–722.
25.
Tejler G, Norberg B, Dufmats M, Nordenskjold B: Survival after treatment for breast cancer in a geographically defined population. Br J Surg 2004; 91: 1307–1312.
26.
Ernst MF, Voogd AC, Coebergh JW, Roukema JA: Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer 2004; 100: 1337–1344.
27.
Ferlicot S, Vincent-Salomon A, Medioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X: Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 2004; 40: 336–341.
28.
Arpino G, Bardou VJ, Clark GM, et al: Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004; 6:R149–R156.
29.
He H, Gonzalez A, Robinson E, Yang WT: Distant metastatic disease manifestations in infiltrating lobular carcinoma of the breast. AJR Am J Roentgenol 2014; 202: 1140–1148.
30.
Ganem EJ, Batal JT: Secondary malignant tumours of the urinary bladder metastatic from primary foci in distant organs. J Urol 1956; 75: 965–972.
31.
Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P: Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 77: 113–120.
32.
Massoud W, Ferlicot S, Hajj P, Awad A, Iaaza LA, Hammoudi Y, Droupy S, Benoit G: Metastatic breast carcinoma to the bladder. Urology 2009; 74: 785–786.
33.
Harris M, Howell A, Chrissohou M, Swindell RI, Hudson M, Sellwood RA: A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23–30.
34.
Sherlock P, Hartmann WH: Adrenal steroids and the pattern of metastases of breast cancer. JAMA 1962; 181: 313–317.
35.
Luczyńska E, Pawlik T, Chwalibóg A, Anioł J, Ryś J: Metastatic Breast Cancer to the Bladder case report and review of literature. J Radiol Case Rep 2010; 4: 19–26.
36.
Ramsey J, Beckman EN, Winters JC: Breast cancer metastatic to the urinary bladder. Ochsner J 2008; 8: 208–212.
37.
Mairy Y, Opsomer R, Donnez J, Van Cangh PJ: [Bladder metastases from breast cancer: 2 cases]. Acta Urol Belg 1982; 50: 87–90.
38.
Cormio L, Sanguedolce F, Di Fino G, Massenio P, Liuzzi G, Ruocco N, Bufo P, Carrieri G: Asymptomatic Bladder Metastasis from Breast Cancer. Case Rep Urol 2014; 2014: 672591.
39.
Soon PS, Lynch W, Schwartz P: Breast cancer presenting initially with urinary incontinence: a case of bladder metastasis from breast cancer. Breast 2004; 13: 69–71.
40.
Schapira D, Asbury R, Wandtke J, Macintosh P: Hematuria secondary to perivesical tumors. N Y State J Med 1980; 80: 67–69.
41.
Vulcano E, Montesano M, Battista C, Carino R, Perrone G, Vincenzi B, Altomare V: Urinary complications from breast cancer metastasis: case report and review of the literature. G Chir 2010; 31: 243–245.
42.
Shah KG, Modi PR, Rizvi J: Breast carcinoma metastasizing to the urinary bladder and retroperitoneum presenting as acute renal failure. Indian J Urol 2011; 27: 135–136.
43.
Lin WC, Chen JH: Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors. J Clin Oncol 2007; 25: 4308–4310.
44.
Gatti G, Zurrida S, Gilardi D, Bassani G, dos Santos GR, Luini A: Urinary bladder metastases from breast carcinoma: review of the literature starting from a clinical case. Tumori 2005; 91: 283–286.
45.
Forster J, Agrawal V, Anathhanam AJ, Spencer N, Biyani CS: Breast carcinoma metastasizing to the urinary bladder presenting as bilateral hydronephrosis treated with ureteral stenting and chemotherapy. Urol Oncol 2006; 24: 33–35.
46.
Herrera FA Jr, Hassanein AH, Cosman BC, Bouvet M: Breast carcinoma metastatic to the gallbladder and urinary bladder. Eur Rev Med Pharmacol Sci 2010; 14: 883–886.
47.
Kleinmann N, Mor Y, Laufer M, Duvdevani M, Fridman E, Ramon J: A solitary metastasis of breast cancer to the urinary bladder. Breast J 2005; 11: 497.
48.
Berger Y, Nissenblatt M, Salwitz J, Lega B: Bladder involvement in metastatic breast carcinoma. J Urol 1992; 147: 137–139.
49.
Perez-Mesa C, Pickren JW, Woodruff MN, Mohallatee A: Metastatic carcinoma of the urinary bladder from primary tumors in the mammary gland of female patients. Surg Gynecol Obstet 1965; 21: 813–818.
50.
Schneidau T, Stroumbakis N, Choudhury M, Eshgi M, Mallouh C: Metastatic breast cancer to the bladder: a case report. Int Urol Nephrol 1995; 27: 297–300.
51.
Winston CB, Hadar O, Teitcher JB, Caravelli JF, Sklarin NT, Panicek DM, Liberman L: Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT. AJR Am J Roentgenol 2000; 175: 795–800.
52.
Grabstald H, Kaufman R: Hydronephrosis secondary to ureteral obstruction by metastatic breast cancer. J Urol 1969; 102: 569–576.
53.
Wong MH, Yiu MK, Ho KL: Metastatic carcinoma of breast in the urinary bladder. Hong Kong Med J 2013; 19: 455–457.
54.
Ghaida RA, Ayoub H, Nasr R, Issa G, Bulbul M: Bladder metastasis from primary breast cancer: a case report and literature review. Cent European J Urol 2012; 66: 177–184.
55.
Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J: Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med 2002; 43: 325–329.
56.
Yoshida S, Nakagomi K, Goto S, Futatsubashi M, Torizuka T: C-choline positron emission tomography in bladder cancer: report of four cases. Int J Urol 2006; 13: 829–831.
57.
Given M, Scott M, Mc Grath JP, Given HF: The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence. Breast 2000; 9: 277–280.
58.
Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L: Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer 1991; 64: 154–158.
59.
Baldwin L, Lee AH, Al-Talib RK, Theaker JM: Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005; 46: 50–56.
60.
Moch H, Humphrey PA, Ulbright TM, et al: WHO Classification of Tumours of the Urinary System and Male Genital Organs, ed 4. Lyon, IARC, 2016.
61.
Zagha RM, Hamawy KJ: Solitary breast cancer metastasis to the bladder: an unusual occurrence. Urol Oncol 2007; 25: 236–239.
62.
Amin MB: Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 2009; 22:S96–S118.
63.
Mostofi FK, Thompson RV, Dean AL Jr: Mucous adenocarcinoma of the urinary bladder. Cancer 1955; 8: 741–758.
64.
Lin F, Liu H: Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. Arch Pathol Lab Med 2014; 138: 1583–1610.
65.
Iguchi C, Nio Y, Itakura M: Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. J Surg Oncol 2003; 83: 85–93.
66.
Al Ibraheemi AA: Case report of metastatic invasive breast lobular carcinoma to the urinary bladder. Int J Hematol Oncol Stem Cell Res 2016; 10: 51–55.
67.
Ines Z, Riadh C, Hatem B, Boutheina L, Leyla M, Tarek D, Jamel BH, Tarek D, Monia H, Khaled R: A case of solitary bladder metastasis from male breast cancer. Pan Arab J Oncol 2011; 4: 8–9.
68.
Lawrentschuk N, Chan Y, Bolton DM: Metastatic breast cancer to the bladder. Breast J 2005; 11: 143.
69.
Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S: Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 2005; 90: 65–70.
70.
McLaren DB, Morrey D, Mason MD: Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol 1997; 43: 171–174.
71.
Din OS, Thanvi N, Ferguson CJ, Kirkbride P: Palliative prostate radiotherapy for symptomatic advanced prostate cancer. Radiother Oncol 2009; 93: 192–196.
72.
Poulakis V, Witzsch U, De Vries R, Becht E: Metastatic breast carcinoma to the bladder: 5-year followup. J Urol 2001; 165: 905.
73.
Ryan PD, Harisinghani M, Lerwill MF, Kaufman DS: Case records of the massachusetts general hospital. Case 6-2006. A 71-year-old woman with urinary incontinence and a mass in the bladder. N Engl J Med 2006; 354: 850–856.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.